StonvexLoading…
StonvexStonvexStonvexCore line items from HCA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2020 2020-12-31 | Annual 2019 2019-12-31 | Annual 2019 2019-09-30 | Annual 2019 2019-06-30 |
|---|---|---|---|---|
Revenue | $51.53B | $51.34B | $12.69B | $12.60B |
Operating Income | $5.43B | $5.24B | Not available | Not available |
Net Income | $3.75B | $3.50B | $612.00M | $783.00M |
EPS (Diluted) | $10.93 | $10.07 | $1.76 | $2.25 |
Total Assets | $47.49B | $45.06B | Not available | Not available |
Total Liabilities | Not available | $45.62B | Not available | Not available |
Cash & Equivalents | $1.79B | $621.00M | Not available | Not available |
Free Cash Flow OCF − CapEx | $6.40B | $3.44B | Not available | Not available |
Shares Outstanding | 339.43M | 338.45M | Not available | Not available |